Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00185887

Enrollment

110

Registered

2005-09-16

Start date

2003-10-31

Completion date

2007-10-31

Last updated

2011-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Distress

Brief summary

To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation

Interventions

DRUGTerbutaline

Terbutaline 250 micrograms intravenously for intrapartum fetal resuscitation. Nitroglycerine 400 micrograms intravenously for intrapartum fetal resuscitation.

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

: * nonreassuring fetal heart rate tracing

Exclusion criteria

- maternal cardiac disease, placental abruption, intrauterine growth restriction, prior cesarean section

Design outcomes

Primary

Measure	Time frame
resolution of abnormal fetal heart tracing	Administration of study medication to resolution of abnormal fetal heart tracing or operative delivery.

Secondary

Measure	Time frame
cesarean section rate	Data analysis
operative vaginal delivery rate	Data analysis
neonatal outcomes	time of delivery to time of discharge

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026